Craig-Hallum downgraded Skye Bioscience (SKYE) to Hold from Buy with a $2 price target
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SKYE:
- Fifth Third buying Comerica, AMD gets OpenAI boost: Morning Buzz
- Promising Phase IIa Results and Favorable Safety Profile Drive Buy Rating for Skye Bioscience’s Nimacimab
- Skye Bioscience downgraded to Neutral from Overweight at Cantor Fitzgerald
- Skye Bioscience Reveals Phase 2a Study Results
- Why Is Skye Bioscience Stock Down 60% Today?